Mitotic inhibitor
WikiDoc Resources for Mitotic inhibitor |
Articles |
---|
Most recent articles on Mitotic inhibitor Most cited articles on Mitotic inhibitor |
Media |
Powerpoint slides on Mitotic inhibitor |
Evidence Based Medicine |
Cochrane Collaboration on Mitotic inhibitor |
Clinical Trials |
Ongoing Trials on Mitotic inhibitor at Clinical Trials.gov Trial results on Mitotic inhibitor Clinical Trials on Mitotic inhibitor at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Mitotic inhibitor NICE Guidance on Mitotic inhibitor
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Mitotic inhibitor Discussion groups on Mitotic inhibitor Patient Handouts on Mitotic inhibitor Directions to Hospitals Treating Mitotic inhibitor Risk calculators and risk factors for Mitotic inhibitor
|
Healthcare Provider Resources |
Causes & Risk Factors for Mitotic inhibitor |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
A mitotic inhibitor is a type of drug derived from natural substances such as plant alkaloids and primarily used in cancer treatment and certain types of cancer research including cytogenetics.[1] Cancer cells are able to grow and eventually metastasize through continuous mitotic division. Generally speaking, mitotic inhibitors prevent cells from undergoing mitosis by disrupting microtubule polymerization, thus preventing cancerous growth. Mitotic inhibitors work by interfering with and halting mitosis (usually during the M phase of the cell cycle), so that the cell will no longer divide.[2] Tubulin, a necessary protein for mitosis to occur, is suppressed by the mitotic inhibitor, preventing mitosis altogether.[3]
Examples of mitotic inhibitors frequently used in the treatment of cancer include paclitaxel, docetaxel, vinblastine, vincristine, and vinorelbine.[4] Colchicine is a mitotic inhibitor used in the treatment of gout.[5]
Use of mitotic inhibitors in cytogenetics
Cytogenetics, the study of chromosomal material by analysis of G-Banded chromosomes, uses mitotic inhibitors extensively. In order to prepare a slide for cytogenetic study, a mitotic inhibitor is added to the cells being studied. This stops the cells during mitosis, while the chromosomes are still visible. Once the cells are centrifuged and placed in a hypotonic solution, they swell, spreading the chromosomes. After preparation, the chromosomes of the cells can be viewed under a microscope to have the banding patterns of the chromosomes examined. This experiment is crucial to many forms of cancer research.
Specific agents
Taxanes
Taxanes are complex terpenes produced by the plants of the genus Taxus (yews). Originally derived from the Pacific yew tree, they are now synthesized artificially. Their principal mechanism is the disruption of the cell's microtubule function by stabilizing microtubule formation. Microtubules are essential to mitotic reproduction, so through the inactivation of the microtubule function of a cell, taxanes inhibit the cell's division.
- Paclitaxel—used to treat lung cancer, ovarian cancer, breast cancer, and advanced forms of Kaposi's sarcoma.[6]
- Docetaxel—used to treat breast, ovarian, and non-small cell lung cancer.[7][8]
Vinca alkaloids
Vinca alkaloids are amines produced by the hallucinogenic plant Catharanthus roseus (Madagascar Periwinkle). Vinca alkaloids inhibit microtubule polymerization, thereby inhibiting mitosis.
- Vinblastine—used to treat leukaemia, Hodgkin's lymphoma, non-small cell lung cancer, breast cancer and testicular cancer. It is also a component in a large number of chemotherapy regimens.[9]
- Vincristine—used to treat lymphoma, breast cancer, lung cancer, and acute lymphoblastic leukemia.[9]
- Vindesine—used to treat leukaemia, lymphoma, melanoma, breast cancer, and lung cancer.[9]
- Vinorelbine—used to treat breast cancer and non-small-cell lung cancer.[9]
Colchicine
Colchicine is an alkaloid derived from the autumn crocus (Colchicum autumnale). It inhibits mitosis by inhibiting microtubule polymerization. While colchicine is not used to treat cancer in humans, it is commonly used to treat acute attacks of gout.[5]
References
- ↑ "What Are the Different Types of Chemotherapy Drugs?". American Cancer Society. Retrieved 2007-08-05.
- ↑ "Definition of mitotic inhibitor". National Cancer Institute. Retrieved 2007-08-05.
- ↑ "Treatment Options: Mitotic Inhibitors". Drug Digest. Retrieved 2007-08-05.
- ↑ "What Are the Different Types of Chemotherapy Drugs?". American Cancer Society. Retrieved 2007-08-05.
- ↑ 5.0 5.1 Cyberbotanica. University of Texas. "Pharmacology of Colchicine." Last updated November 5, 1997. Last accessed July 14, 2007.
- ↑ Saville M, Lietzau J, Pluda J, Feuerstein I, Odom J, Wilson W, Humphrey R, Feigal E, Steinberg S, Broder S (1995). "Treatment of HIV-associated Kaposi's sarcoma with paclitaxel". Lancet. 346 (8966): 26–8. PMID 7603142. Unknown parameter
|month=
ignored (help) - ↑ Lyseng-Williamson KA, Fenton C. Docetaxel: a review of its use in metastatic breast cancer. Drugs 2005;65(17):2513-31.
- ↑ Clarke SJ, Rivory LP. Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet 1999;36(2):99-114
- ↑ 9.0 9.1 9.2 9.3 "Vincristine (Oncovin®)". Retrieved 2007-08-05.